US6255065B1 - Bacillus strain and antibiotic screening method - Google Patents

Bacillus strain and antibiotic screening method Download PDF

Info

Publication number
US6255065B1
US6255065B1 US09/319,778 US31977899A US6255065B1 US 6255065 B1 US6255065 B1 US 6255065B1 US 31977899 A US31977899 A US 31977899A US 6255065 B1 US6255065 B1 US 6255065B1
Authority
US
United States
Prior art keywords
reporter
gene
reporter gene
cell division
bacillus strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/319,778
Inventor
Jeffery Errington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Assigned to ISIS INNOVATION LIMITED reassignment ISIS INNOVATION LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ERRINGTON, JEFFERY
Application granted granted Critical
Publication of US6255065B1 publication Critical patent/US6255065B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus

Definitions

  • the assay method described herein targets a group of related activities functioning in cell division.
  • the assay is based on the observation that activation of the sporulation-specific transcription factor ⁇ F , which has been extensively studied in several laboratories (reviewed by Errington, 1996 , Trends in Genetics 12, 31-34), requires the completion of cell division.
  • Synthesis of the sigma factor begins at the onset of sporulation but its product is initially held in an inactive state by the action of an anti-sigma factor, SpollAB. Release from inhibition requires the concerted action of at least two other proteins, SpollAA and SpollE, through a series of biochemical interactions that are now well characterised (Errington, 1996). These proteins serve to allow release of ⁇ F activity only after the sporulating cell has undergone asymmetric cell division and to restrict the ⁇ F activity to the smaller prespore cell type. This mechanism works in such a way that it renders ⁇ F activation dependent on septation. Thus, mutants or genetically engineered strains of B.
  • subtilis that are prevented from undergoing septation because of the absence of essential cell division gene products such as ftsZ (Beall and Lutkenhaus, 1991 , Genes Devel . 5, 447-455), divlC (Levin and Losick, 1994 , J. Bacteriol . 176, 716-722) or ftsL (Daniel, R. A. and Errington, J., unpublished results), synthesise but do not activate ⁇ F .
  • the dependence of ⁇ F activation on septation is herein used as the basis for a sensitive assay for inhibitors of cell division. Although the assay is based on inhibition of the specialised asymmetric cell division which occurs at the onset of sporulation, there is ample evidence that this process is functionally very similar to cell division in vegetative cells.
  • the invention provides a Bacillus strain having a chromosome with two artificially introduced reporter genes, a first reporter gene having a promoter which is dependent on active ⁇ F or ⁇ E factors, and a second reporter gene which provides a measure of the synthesis of the (inactive) ⁇ F or ⁇ E factor.
  • the invention provides a method of determining whether an agent inhibits cell division in Bacillus species, which method comprises inducing the Bacillus strain as described to sporulate in the presence of the agent, and observing expression of the first and second reporter genes. It is thought that the property of inhibiting cell division, is indicative of actual or potential anti-microbial properties in the agent. The method is thus expected to be useful for screening possible anti-microbial agents.
  • the invention provides a method which comprises inducing the Bacillus strain as described to sporulate in the presence of an agent, observing expression of the first and second reporter genes and thereby determining that the agent inhibits cell division in the Bacillus species, and using the agent as an antibiotic to kill or inhibit the growth of bacteria.
  • the assay described below is based on use of ⁇ F activation but it could also have used ⁇ E , another sporulation specific sigma factor that is dependent on asymmetric septation (Stragier et al, 1988, Cell, 52, 697-704).
  • ⁇ E another sporulation specific sigma factor that is dependent on asymmetric septation
  • the dependence of ⁇ E on septation is now thought to be an indirect effect caused by the dependence of ⁇ E activity on ⁇ F activation (see Errington, 1996).
  • Use of an ⁇ E -dependent reporter gene would be less desirable as it would probably detect more non-specific inhibitors than with ⁇ F .
  • Bacillus species may be used that is capable of sporulating under suitable conditions and for which genetic constructions can be made.
  • B. subtilis is conveniently accessible and well characterised and is preferred.
  • the Bacillus strain constructed has a chromosome with two reporter genes each linked to a different promoter.
  • a reporter gene is one which on expression gives rise to an easily detected or observed phenotype.
  • the expressed protein may be an enzyme which acts on a substance to give a product that is easily observed e.g. because it is coloured or chemiluminescent or fluorescent.
  • Reporter genes capable of being expressed in Bacillus species are well known and documented in the literature.
  • the two reporter genes are preferably chosen so that their products can be readily assayed simultaneously. lacZ has been used for more than ten years with great success in B. subtilis . There are a range of useful substrates that generate coloured or fluorescent products upon hydrolysis by ⁇ -galactosidase.
  • the uidA gene of E. coli also known as the gusA gene, has recently been harnessed for similar purposes, and the range of substrates available for the gene product, ⁇ -glucuronidase, is similar to that of ⁇ -galactosidase.
  • the assay uses a specific strain of B. subtilis containing two reporter genes.
  • the first (gpr-uidA) provides a means of monitoring ⁇ F (or ⁇ E ) activity: its promoter is ⁇ F (or ⁇ E )-dependent and it directs the production of an enzyme, ⁇ -glucuronidase, the activity of which can be readily measured by spectrophotometry or spectrofluorimetry.
  • the second reporter gene (spollA-lacZ), which monitors expression of the gene encoding ⁇ F (or ⁇ E ), e.g.
  • the product of the reporter gene is an enzyme, ⁇ -galactosidase, that can readily be measured.
  • enzyme enzyme
  • this B. subtilis strain would be induced to sporulate by the resuspension method (Sterlini and Mandelstam, 1969 , Biochem. J . 113, 29-37; Partridge and Errington, 1993 , Mol Microbiol 8, 945-955).
  • the culture would be dispensed into the wells of a microtitre plate just before the onset of asymmetric cell division (e.g. after 1 h at 37° C.). Individual wells would contain one or more potential inhibitors.
  • the microtitre plate cultures After a period of incubation sufficient for induction of the spollA operon and activation of ⁇ F (or ⁇ E ), the microtitre plate cultures would be assayed for the two reporter activities by standard methods. Potential “hits” would show inhibition of ⁇ -glucuronidase activity but normal ⁇ -galactosidase activity (indicating synthesis but not activation of ⁇ F (or ⁇ E ))
  • test compounds can be dropped onto a lawn of sporulating cells on a solid surface (e.g. agar).
  • a solid surface e.g. agar
  • the effect of the test compounds on reporter gene activity will be assessed by the colour or fluorescence produced by hydrolysis of colourigenic or fluorogenic substrates incorporated into the solid medium.
  • Two kinds of compounds might be expected to be detected by the assay.
  • First the desired compounds that inhibit asymmetric cell division.
  • the two classes could be readily distinguished by light microscopy because the latter class should form normal asymmetric septa.
  • any compounds identified would be good potential candidates for development as antimicrobial agents because cell division is such a central target. Moreover, since cell division proteins tend to be highly conserved in bacteria, it is likely that broad spectrum inhibitors could be obtained.
  • FIG. 1 is a graph showing the effect of depletion of FtsZ on expression of spollAA-lacZ and gpr-uidA;
  • FIGS. 2A-2D is a set of four graphs A, B, C, and D, showing detection of antibiotics affecting cell wall synthesis or cell division;
  • FIG. 3 is a graph showing use of 96 well microtitire plates to induce sporulation and reporter gene expression in a format suitable for high throughput screening.
  • FIG. 1 shows the effect of depletion of FtsZ on expression of spollAA-lacZ (circles) and gpr-uidA (squares).
  • Filled symbols indicate the reporter enzyme activities in the presence of FtsZ, and open symbols, in the culture from which it was depleted by removal of the inducer, IPTG.
  • inducer both reporter genes were strongly induced 1 to 2 h after the onset of sporulation, whereas in the absence of the inducer, resulting in inhibition of cell division, only the spollAA-lacZ reporter, producing ⁇ -galactosidase, was activated. Because ⁇ F activity normally leads to repression of its own gene during sporulation, spollAA-lacZ expression is actually enhanced in the absence of active ⁇ F .
  • the bacterial strain used (846) carried the following genetic markers: trpC2 ⁇ (amyE::gpr-uidA aphA-3) ( ⁇ 105J19) spollAA-lacZ cat.
  • ⁇ -galactosidase (from the lacZ gene) provides an indication of ⁇ F synthesis and ⁇ -glucuronidase (from the uidA gene) a measure of ⁇ F activation (dependent on cell division).
  • the strain was induced to sporulate by standard methods (Partridge and Errington, 1993, Mol. Microbiol. 8, 945-955).
  • subtilis strains were obtained for cells grown in a microtitre plate format.
  • cells of strain 846 were induced to sporulate by the normal method involving resuspension in a starvation medium (Partridge and Errington, 1993).
  • the culture was divided into two portions. One portion was allowed to continue sporulating in the glass flask, as usual (filled symbols in FIG. 3 ).
  • the other half of the culture was dispensed, in 50 ⁇ l aliquots, into the wells of a standard 8 by 12 microtitre plate with 360 ⁇ l wells (open symbols).
  • microtitre plate was incubated alongside the glass flask, shaking at 37° C. At intervals, the contents of one well of the plate and 50 ⁇ l of the flask culture were removed and assayed for ⁇ -galactosidase (circles) and ⁇ -glucuronidase (squares). As shown in FIG. 3, the time courses showed good induction of both reporter enzymes in the microtitre plate sporulated culture, though there were minor qualitative differences in their time courses from those of the flask culture. Cells induced to sporulate in microtitre plates were also observed to form spores with similar efficiency to those in flasks. We conclude that the sporulation experiments required for the assay to be run in high throughput mode can be done in readily available microtitre plates.

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A Bacillus strain has a chromosome with two reporter genes, a first reporter gene having a promoter which is dependent on active σF factor, and a second gene having a promoter regulated similarly to the gene encoding the sigma factor. A method of using Bacillus strain in an assay for screening putative antibiotics.

Description

The assay method described herein targets a group of related activities functioning in cell division. The assay is based on the observation that activation of the sporulation-specific transcription factor σF, which has been extensively studied in several laboratories (reviewed by Errington, 1996, Trends in Genetics 12, 31-34), requires the completion of cell division.
Synthesis of the sigma factor begins at the onset of sporulation but its product is initially held in an inactive state by the action of an anti-sigma factor, SpollAB. Release from inhibition requires the concerted action of at least two other proteins, SpollAA and SpollE, through a series of biochemical interactions that are now well characterised (Errington, 1996). These proteins serve to allow release of σF activity only after the sporulating cell has undergone asymmetric cell division and to restrict the σF activity to the smaller prespore cell type. This mechanism works in such a way that it renders σF activation dependent on septation. Thus, mutants or genetically engineered strains of B. subtilis that are prevented from undergoing septation because of the absence of essential cell division gene products such as ftsZ (Beall and Lutkenhaus, 1991, Genes Devel. 5, 447-455), divlC (Levin and Losick, 1994, J. Bacteriol. 176, 716-722) or ftsL (Daniel, R. A. and Errington, J., unpublished results), synthesise but do not activate σF. The dependence of σF activation on septation is herein used as the basis for a sensitive assay for inhibitors of cell division. Although the assay is based on inhibition of the specialised asymmetric cell division which occurs at the onset of sporulation, there is ample evidence that this process is functionally very similar to cell division in vegetative cells.
In one aspect the invention provides a Bacillus strain having a chromosome with two artificially introduced reporter genes, a first reporter gene having a promoter which is dependent on active σF or σE factors, and a second reporter gene which provides a measure of the synthesis of the (inactive) σF or σE factor.
In another aspect the invention provides a method of determining whether an agent inhibits cell division in Bacillus species, which method comprises inducing the Bacillus strain as described to sporulate in the presence of the agent, and observing expression of the first and second reporter genes. It is thought that the property of inhibiting cell division, is indicative of actual or potential anti-microbial properties in the agent. The method is thus expected to be useful for screening possible anti-microbial agents.
In another aspect the invention provides a method which comprises inducing the Bacillus strain as described to sporulate in the presence of an agent, observing expression of the first and second reporter genes and thereby determining that the agent inhibits cell division in the Bacillus species, and using the agent as an antibiotic to kill or inhibit the growth of bacteria.
The assay described below is based on use of σF activation but it could also have used σE, another sporulation specific sigma factor that is dependent on asymmetric septation (Stragier et al, 1988, Cell, 52, 697-704). The dependence of σE on septation is now thought to be an indirect effect caused by the dependence of σE activity on σF activation (see Errington, 1996). Use of an σE-dependent reporter gene would be less desirable as it would probably detect more non-specific inhibitors than with σF.
Any Bacillus species may be used that is capable of sporulating under suitable conditions and for which genetic constructions can be made. B. subtilis is conveniently accessible and well characterised and is preferred.
The Bacillus strain constructed has a chromosome with two reporter genes each linked to a different promoter. A reporter gene is one which on expression gives rise to an easily detected or observed phenotype. For example, the expressed protein may be an enzyme which acts on a substance to give a product that is easily observed e.g. because it is coloured or chemiluminescent or fluorescent. Reporter genes capable of being expressed in Bacillus species are well known and documented in the literature. The two reporter genes are preferably chosen so that their products can be readily assayed simultaneously. lacZ has been used for more than ten years with great success in B. subtilis. There are a range of useful substrates that generate coloured or fluorescent products upon hydrolysis by β-galactosidase. The uidA gene of E. coli, also known as the gusA gene, has recently been harnessed for similar purposes, and the range of substrates available for the gene product, β-glucuronidase, is similar to that of β-galactosidase.
In a preferred form, the assay uses a specific strain of B. subtilis containing two reporter genes. The first (gpr-uidA) provides a means of monitoring σF (or σE) activity: its promoter is σF (or σE)-dependent and it directs the production of an enzyme, β-glucuronidase, the activity of which can be readily measured by spectrophotometry or spectrofluorimetry. The second reporter gene (spollA-lacZ), which monitors expression of the gene encoding σF (or σE), e.g. by virtue of having a promoter regulated similarly to the gene encoding sigma factor, provides a check for non-specific effects on sporulation or general inhibitors of gene expression. Again the product of the reporter gene is an enzyme, β-galactosidase, that can readily be measured. By using appropriate (enzyme) substrates, the two enzyme activities could be measured simultaneously.
To use the assay, this B. subtilis strain would be induced to sporulate by the resuspension method (Sterlini and Mandelstam, 1969, Biochem. J. 113, 29-37; Partridge and Errington, 1993, Mol Microbiol 8, 945-955). The culture would be dispensed into the wells of a microtitre plate just before the onset of asymmetric cell division (e.g. after 1 h at 37° C.). Individual wells would contain one or more potential inhibitors. After a period of incubation sufficient for induction of the spollA operon and activation of σF (or σE), the microtitre plate cultures would be assayed for the two reporter activities by standard methods. Potential “hits” would show inhibition of β-glucuronidase activity but normal β-galactosidase activity (indicating synthesis but not activation of σF (or σE))
Alternatively, test compounds can be dropped onto a lawn of sporulating cells on a solid surface (e.g. agar). In this case, the effect of the test compounds on reporter gene activity will be assessed by the colour or fluorescence produced by hydrolysis of colourigenic or fluorogenic substrates incorporated into the solid medium.
Two kinds of compounds might be expected to be detected by the assay. First, the desired compounds that inhibit asymmetric cell division. Second, compounds that interfere in some way with the protein—protein interactions, or the kinase or phosphatase activities known to be involved in σF (or σE) regulation. These would be of purely academic interest (at least in the short term). The two classes could be readily distinguished by light microscopy because the latter class should form normal asymmetric septa.
Irrespective of the specific biomolecule affected in the screen, any compounds identified would be good potential candidates for development as antimicrobial agents because cell division is such a central target. Moreover, since cell division proteins tend to be highly conserved in bacteria, it is likely that broad spectrum inhibitors could be obtained.
Reference is directed to the accompanying drawings in which:
FIG. 1 is a graph showing the effect of depletion of FtsZ on expression of spollAA-lacZ and gpr-uidA;
FIGS. 2A-2D is a set of four graphs A, B, C, and D, showing detection of antibiotics affecting cell wall synthesis or cell division;
FIG. 3 is a graph showing use of 96 well microtitire plates to induce sporulation and reporter gene expression in a format suitable for high throughput screening.
The following examples illustrate the invention.
EXAMPLE 1
To illustrate the utility of the assay, a strain was constructed, containing the two reporter genes mentioned above (i.e., gpr-uidA and spollAA-lacZ) but in addition, a genetic insertion which renders the essential cell-division gene ftsZ dependent on an inducer chemical IPTG (Beall and Lutkenhaus, 1991). The strain was induced to sporulate under conditions in which the inducer was either present or absent and the two reporter activities were measured. FIG. 1 shows the effect of depletion of FtsZ on expression of spollAA-lacZ (circles) and gpr-uidA (squares). Filled symbols indicate the reporter enzyme activities in the presence of FtsZ, and open symbols, in the culture from which it was depleted by removal of the inducer, IPTG. As shown, in the presence of inducer, both reporter genes were strongly induced 1 to 2 h after the onset of sporulation, whereas in the absence of the inducer, resulting in inhibition of cell division, only the spollAA-lacZ reporter, producing β-galactosidase, was activated. Because σF activity normally leads to repression of its own gene during sporulation, spollAA-lacZ expression is actually enhanced in the absence of active σF. Samples taken about 180 min after the initiation of sporulation and assayed for β-galactosidase and β-glucuronidase would thus readily detect specific inhibition of σF activity. Note that in the absence of functional FtsZ, gpr-uidA activity is abolished (indicating that σF does not become active), whereas spollAA-lacZ expression (leading to σF synthesis) is enhanced, presumably because σF activity normally leads to repression of its own gene later in sporulation.
EXAMPLE 2
To show that the assay method could detect actual inhibitors of cell division, the experiments shown in FIG. 2 were performed. The bacterial strain used (846) carried the following genetic markers: trpC2 Ω(amyE::gpr-uidA aphA-3) (φ105J19) spollAA-lacZ cat. Thus, β-galactosidase (from the lacZ gene) provides an indication of σF synthesis and β-glucuronidase (from the uidA gene) a measure of σF activation (dependent on cell division). The strain was induced to sporulate by standard methods (Partridge and Errington, 1993, Mol. Microbiol. 8, 945-955). Immediately after induction, the culture was divided into several portions, which were treated with different known antibiotics. In the control (untreated) culture (panel A), P-galactosidase (filled squares) and β-glucuronidase (open squares) activities produced from the two reporter genes followed their normal kinetics (Errington and Mandelstam, 1986, J. Gen. Microbiol. 132, 2967-2976; Partridge and Errington, 1993) (see also FIG. 1). In the presence of antibiotics that affect cell wall synthesis or cell division (bacitracin [50 μg/ml; panel B] and carbenicillin [110 μg/ml; panel C]) σF synthesis occurred, as indicated by accumulation of β-galactosidase with near normal kinetics, but its activation was blocked, as indicated by the elimination of β-glucuronidase activity. In contrast, with a general inhibitor of protein synthesis, erythromycin (50 μg/ml), both reporter genes were blocked (panel D).
Note that in the case of bacitracin (and vancomycin; data not shown), which affects cell wall synthesis generally, addition of the inhibitor at the concentration indicated caused a slight reduction in expression of the spollAA-lacZ reporter (as well as a block in gpr-uidA expression). It is likely that such a reduction in expression would not occur with inhibitors of proteins required specifically for formation of the septum, though no such inhibitors are presently available. Thus, of test chemicals that block gpr-uidA expression, those giving the highest levels of spollAA-lacZ expression would be most likely to affect targets required specifically for septation. Nevertheless, compounds giving a partial reduction in spollAA-lacZ expression might still be of commercial interest, as functions involved in cell wall synthesis are likely, in general, to provide the necessary selective toxicity needed for good antibiotics.
Note also that in the case of carbenicillin, cell lysis, as indicated by a fall in culture optical density (OD600), began about 2 to 3 hours after the initiation of sporulation. Although this lysis probably occurs too late to explain the large difference in reporter activity, it provides an indication of a possible source of “false positive” results that might arise when the assay is put into practice. Since the gpr-uidA reporter is turned on about 1 hour later than the spollAA-lacZ reporter, it is possible that agents causing slow killing of the cells would have differential effects on expression of the earlier and later reporter genes. Agents having this effect through cell lysis could be detected and excluded, if necessary, by measuring the optical density of the culture about 3 or 4 hours after initiation of sporulation.
EXAMPLE 3
To confirm that the results obtained above with batch grown B. subtilis strains could be obtained for cells grown in a microtitre plate format, cells of strain 846 (see above) were induced to sporulate by the normal method involving resuspension in a starvation medium (Partridge and Errington, 1993). Immediately after resuspension, the culture was divided into two portions. One portion was allowed to continue sporulating in the glass flask, as usual (filled symbols in FIG. 3). The other half of the culture was dispensed, in 50 μl aliquots, into the wells of a standard 8 by 12 microtitre plate with 360 μl wells (open symbols). The microtitre plate was incubated alongside the glass flask, shaking at 37° C. At intervals, the contents of one well of the plate and 50 μl of the flask culture were removed and assayed for β-galactosidase (circles) and β-glucuronidase (squares). As shown in FIG. 3, the time courses showed good induction of both reporter enzymes in the microtitre plate sporulated culture, though there were minor qualitative differences in their time courses from those of the flask culture. Cells induced to sporulate in microtitre plates were also observed to form spores with similar efficiency to those in flasks. We conclude that the sporulation experiments required for the assay to be run in high throughput mode can be done in readily available microtitre plates.

Claims (10)

What is claimed is:
1. A Bacillus strain having a chromosome with two artificially introduced reporter genes, a first reporter gene having a promoter which is dependent on active σF or σE factors, and a second reporter gene whose promoter is regulated similarly to the promoter of the gene encoding σF or σE factor.
2. A Bacillus strain as claimed in claim 1, wherein the promoter of the first reporter gene is that of the gpr gene and the promoter of the second reporter gene is that of the spollAA gene.
3. A Bacillus strain as claimed in claim 1, wherein the reporter genes are lacZ and uidA.
4. A Bacillus strain as claimed in claim 1, which is a B. subtilis strain.
5. A method of determining whether an agent inhibits cell division in Bacillus species, which method comprises inducing the Bacillus strain of claim 1 to divide asymmetrically in the presence of the agent, and observing expression of the first and second reporter genes, wherein expression of the second reporter gene but not the first reporter gene indicates that the agent inhibits cell division.
6. The method of claim 5 wherein asymmetric division is induced by inducing sporulation.
7. A method as claimed in claim 5, wherein the two reporter genes are expressed as enzymes, the activities of which are observed by fluorimetry or spectrophotometry.
8. A method as claimed in claim 5, wherein the Bacillus strain is induced to sporulate and is contacted, just prior to asymmetric cell division, with the agent.
9. A method as claimed in claim 5, wherein, in a case where expression of the first reporter gene is observed to be reduced relative to the second reporter gene, the cells are examined to determine whether normal asymmetric septa have formed.
10. A method which comprises:
inducing the Bacillus strain of claim 1 to sporulate in the presence of an agent;
observing expression of the first and second reporter genes, wherein expression of the second reporter gene but not the first reporter gene indicates that the agent inhibits cell division in the Bacillus species; and
using the agent identified as inhibiting cell division as an antibiotic to kill or inhibit cell division of bacteria.
US09/319,778 1996-12-12 1997-12-11 Bacillus strain and antibiotic screening method Expired - Fee Related US6255065B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9625832 1996-12-12
GBGB9625832.2A GB9625832D0 (en) 1996-12-12 1996-12-12 Bacillus strain and assay method
PCT/GB1997/003414 WO1998026088A1 (en) 1996-12-12 1997-12-11 Bacillus strain and antibiotic screening method

Publications (1)

Publication Number Publication Date
US6255065B1 true US6255065B1 (en) 2001-07-03

Family

ID=10804336

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/319,778 Expired - Fee Related US6255065B1 (en) 1996-12-12 1997-12-11 Bacillus strain and antibiotic screening method

Country Status (7)

Country Link
US (1) US6255065B1 (en)
EP (1) EP0944735B1 (en)
JP (1) JP4414000B2 (en)
DE (1) DE69725168T2 (en)
ES (1) ES2206756T3 (en)
GB (1) GB9625832D0 (en)
WO (1) WO1998026088A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100997044B1 (en) 2008-04-11 2010-11-29 재단법인서울대학교산학협력재단 Sigma factor r and a method for increasing production of antibiotics using sigma factor r

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063578A (en) * 1998-10-22 2000-05-16 Signal Pharmaceuticals, Inc. Dual reporter system and methods of use therefor
GB9824682D0 (en) * 1998-11-10 1999-01-06 Isis Innovation Bacillus strain and assay method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174477A1 (en) 1984-08-14 1986-03-19 MERCK PATENT GmbH Means and method for determining antimicrobial-activen substances
WO1996035804A1 (en) 1995-05-08 1996-11-14 Merck & Co., Inc. A novel biochemical interaction in bacteria
WO1997000325A1 (en) 1995-06-14 1997-01-03 Isis Innovation Limited Bacillus strain and sporulation assay method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174477A1 (en) 1984-08-14 1986-03-19 MERCK PATENT GmbH Means and method for determining antimicrobial-activen substances
WO1996035804A1 (en) 1995-05-08 1996-11-14 Merck & Co., Inc. A novel biochemical interaction in bacteria
WO1997000325A1 (en) 1995-06-14 1997-01-03 Isis Innovation Limited Bacillus strain and sporulation assay method

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
D. Sun et al., "Effect of chromosome location of Bacillus subtilis forespore genes on their spo gene dependence and transcription by Eo-F : Identification of features of good Eo-F-dependent promoters", Journal of Bacteriology, vol. 173, No. 24, pp. 7867-7874, Dec. 1991.
J. Errington et al., Determination of cell fate in Bacillus subtilis, vol. 12, No. 1, Reviews, pp. 31-34, Jan. 1996.
Lewin. 1990. Genes IV. Oxford University Press, p. 817. *
P. Stragier et al., "Processing of a sporulation sigma factor in Bacillus subtilis: How morphological structure could control gene expression", Cell, vol. 52, pp. 697-704, Mar. 11, 1988.
R. Passmore et al., "A companion to medical studies", General scope of chemotherapy, vol. 2, pp. 20.9-20.31, 1970.
Sussman et al. 1991 Cloning, nucleotide sequence, and regulation of the Bacillus subtilis gpr gene, which codes for the protease that initiates degradation of small, acid-soluble proteins during spore germination. Journal of Bacteriology. vol. 173 (1): 29.*
W. Haldenwang et al., "The sigma factors of Bacillus subtilis", Microbiological Reviews, vol. 59, No. 1, pp. 1-30, Mar. 1995.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100997044B1 (en) 2008-04-11 2010-11-29 재단법인서울대학교산학협력재단 Sigma factor r and a method for increasing production of antibiotics using sigma factor r

Also Published As

Publication number Publication date
JP2001510335A (en) 2001-07-31
GB9625832D0 (en) 1997-01-29
DE69725168T2 (en) 2004-07-15
EP0944735B1 (en) 2003-09-24
ES2206756T3 (en) 2004-05-16
WO1998026088A1 (en) 1998-06-18
EP0944735A1 (en) 1999-09-29
DE69725168D1 (en) 2003-10-30
JP4414000B2 (en) 2010-02-10

Similar Documents

Publication Publication Date Title
Shockman et al. Bacterial walls, peptidoglycan hydrolases, autolysins, and autolysis
Thomashow et al. Role of a phenazine antibiotic from Pseudomonas fluorescens in biological control of Gaeumannomyces graminis var. tritici
Wu et al. Prespore-specific gene expression in Bacillus subtilisis driven by sequestration of SpoIIE phosphatase to the prespore side of the asymmetric septum
US6255065B1 (en) Bacillus strain and antibiotic screening method
US6174678B1 (en) Methods and compositions for modulation of bacterial topoisomerase enzymes
Ruzal et al. In Bacillus subtilis DegU-P is a positive regulator of the osmotic response
US6027909A (en) Bacillus strain and sporulation assay method
Ferencko et al. Esterase activity as a novel parameter of spore germination in Bacillus anthracis
EP1129213B1 (en) Bacillus strain and assay methods
Wachi et al. Irregular nuclear localization and anucleate cell production in Escherichia coli induced by a Ca2+ chelator, EGTA
Sharrock et al. Suppression of defective-sporulation phenotypes by the Bacillus subtilis mutation rev4
EP0944734B1 (en) Bacillus strain and antibiotic screening method
Kirsch et al. The use of β-galactosidase gene fusions to screen for antibacterial antibiotics
US20070298413A1 (en) Topoisomerase Modulators Assays
WO1999023244A1 (en) Methods and compositions for modulation of bacterial topoisomerase enzymes
Warburg et al. A detailed study of gerJ mutants of Bacillus subtilis
Osburne et al. Phenotypes conferred by the Bacillus subtilis recM13 mutation and the din23 fusion
CA2492238A1 (en) Method for identifying cellular growth inhibitors
KR20030081342A (en) Method for Identifying Modulators of Transcription
AU2004245739B2 (en) Screen for novel protein inhibitors based upon engineered cell line containing an inducible overactivity gene and compensatory gene
EP1141397A1 (en) Method of sequence identification
WO1999067636A1 (en) Method for identifying tyrphostin-like inhibitors of eukaryotic cell processes

Legal Events

Date Code Title Description
AS Assignment

Owner name: ISIS INNOVATION LIMITED, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ERRINGTON, JEFFERY;REEL/FRAME:010080/0433

Effective date: 19990113

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REFU Refund

Free format text: REFUND - SURCHARGE, PETITION TO ACCEPT PYMT AFTER EXP, UNINTENTIONAL (ORIGINAL EVENT CODE: R2551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20130703